期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 54, 期 4, 页码 1172-1175出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201409344
关键词
albumin; carbon monoxide; CORM; metalloproteins; prodrugs
资金
- FCT
- EU
- EPSRC
- EPSRC [EP/M003647/1] Funding Source: UKRI
- MRC [MC_PC_14116] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/M003647/1] Funding Source: researchfish
- Medical Research Council [MC_PC_14116] Funding Source: researchfish
We demonstrate that Ru-II(CO)(2)-protein complexes, formed by the reaction of the hydrolytic decomposition products of [fac-RuCl((2)-H2NCH2CO2)(CO)(3)] (CORM-3) with histidine residues exposed on the surface of proteins, spontaneously release CO in aqueous solution, cells, and mice. CO release was detected by mass spectrometry (MS) and confocal microscopy using a CO-responsive turn-on fluorescent probe. These findings support our hypothesis that plasma proteins act as CO carriers after invivo administration of CORM-3. CO released from a synthetic bovine serum albumin (BSA)-Ru-II(CO)(2) complex leads to downregulation of the cytokines interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)- in cancer cells. Finally, administration of BSA-Ru-II(CO)(2) in mice bearing a colon carcinoma tumor results in enhanced CO accumulation at the tumor. Our data suggest the use of Ru-II(CO)(2)-protein complexes as viable alternatives for the safe and spatially controlled delivery of therapeutic CO invivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据